Qube Research & Technologies (QRT)’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.66M | Buy |
625,409
+153,547
| +33% | +$1.88M | 0.01% | 1070 |
|
2025
Q1 | $6.76M | Buy |
471,862
+360,071
| +322% | +$5.16M | 0.01% | 1068 |
|
2024
Q4 | $1.78M | Buy |
+111,791
| New | +$1.78M | ﹤0.01% | 1529 |
|
2024
Q3 | – | Sell |
-38,002
| Closed | -$757K | – | 2777 |
|
2024
Q2 | $757K | Sell |
38,002
-65,418
| -63% | -$1.3M | ﹤0.01% | 1704 |
|
2024
Q1 | $2.06M | Sell |
103,420
-16
| -0% | -$319 | ﹤0.01% | 1480 |
|
2023
Q4 | $2.32M | Buy |
103,436
+30,203
| +41% | +$677K | ﹤0.01% | 1232 |
|
2023
Q3 | $1.48M | Buy |
73,233
+57,040
| +352% | +$1.15M | ﹤0.01% | 1251 |
|
2023
Q2 | $414K | Buy |
+16,193
| New | +$414K | ﹤0.01% | 1492 |
|
2022
Q4 | – | Sell |
-18,032
| Closed | -$393K | – | 2391 |
|
2022
Q3 | $393K | Sell |
18,032
-1,168
| -6% | -$25.5K | ﹤0.01% | 1502 |
|
2022
Q2 | $525K | Sell |
19,200
-9,408
| -33% | -$257K | ﹤0.01% | 1374 |
|
2022
Q1 | $958K | Buy |
+28,608
| New | +$958K | 0.01% | 1178 |
|
2021
Q4 | – | Sell |
-8,899
| Closed | -$278K | – | 2519 |
|
2021
Q3 | $278K | Sell |
8,899
-7,126
| -44% | -$223K | ﹤0.01% | 1517 |
|
2021
Q2 | $583K | Buy |
16,025
+6,898
| +76% | +$251K | 0.01% | 1196 |
|
2021
Q1 | $399K | Buy |
9,127
+4,586
| +101% | +$200K | 0.01% | 1306 |
|
2020
Q4 | $208K | Buy |
+4,541
| New | +$208K | ﹤0.01% | 1514 |
|
2018
Q4 | – | Sell |
-1,749
| Closed | -$120K | – | 335 |
|
2018
Q3 | $120K | Buy |
1,749
+1,575
| +905% | +$108K | 0.02% | 697 |
|
2018
Q2 | $10K | Buy |
+174
| New | +$10K | 0.01% | 758 |
|